HEPATIQ, the ultimate liver test for predicting outcomes.
HEPATIQ calculates the PHM™ index of liver disease severity. PHM™ has been proven to be an accurate predictor of clinical outcomes in the prospective seven year multi-center HALT-C trial of 1056 patients and A2ALL study for regeneration of liver function after an adult-to-adult liver donor liver transplant.
HEPATIQ has been cleared by the FDA for sale.
Dipu Ghosh, MSEE, MBA, CEO, firstname.lastname@example.org
John Hoefs, MD, COO, email@example.com
Brands: HEPATIQ automatically analyses nuclear medicine liver images to calculate PHM. Patients with high-risk PHM have a 15-fold increase in risk for hepatic decompensation or liver-related death.